🇺🇸 FDA
Pipeline program

Sonelokimab, Placebo is a sterile solution in a single use prefilled syringe (pfs) intended for subcutaneous administration

M1095-PSA-301

Phase 3 small_molecule active

Quick answer

Sonelokimab, Placebo is a sterile solution in a single use prefilled syringe (pfs) intended for subcutaneous administration for Psoriatic arthritis is a Phase 3 program (small_molecule) at MoonLake Immunotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
MoonLake Immunotherapeutics
Indication
Psoriatic arthritis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials